Our study corroborates these findings, as we identified abnormal overexpression of ADAM9, ADAM10, ADAM15, and ADAM17 in liver cancer tissues through both GEPIA website analysis and PCR experiments. This evidence concerns the gene ADAM17 and liver cancer.